Serina Therapeutics Files 8-K for Other Event
Ticker: SER · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $13.20, $4,987,818, $18.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: other-events, filing-update
TL;DR
Serina Therapeutics filed an 8-K for an 'Other Event' on 6/6/24, details TBD.
AI Summary
Serina Therapeutics, Inc. (formerly AgeX Therapeutics, Inc.) filed an 8-K on June 10, 2024, reporting an "Other Event" that occurred on June 6, 2024. The filing does not provide specific details about the event itself, only that it is being reported under Item 8.01.
Why It Matters
This filing indicates a material event has occurred for Serina Therapeutics, but the lack of detail requires further investigation to understand its implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K for an 'Other Event' without immediate disclosed details, creating uncertainty about the nature and impact of the event.
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Registrant
- AgeX Therapeutics, Inc. (company) — Former company name
- June 6, 2024 (date) — Date of earliest event reported
- June 10, 2024 (date) — Filing date
FAQ
What specific event is Serina Therapeutics reporting under Item 8.01?
The filing does not specify the nature of the 'Other Event' that occurred on June 6, 2024.
When did the reported event take place?
The earliest event reported occurred on June 6, 2024.
What is the filing date of this 8-K?
This Form 8-K was filed on June 10, 2024.
What was Serina Therapeutics' former name?
Serina Therapeutics, Inc. was formerly known as AgeX Therapeutics, Inc.
Under which item of the 8-K is this event being reported?
The event is being reported under 'Other Events' (Item 8.01).
Filing Stats: 1,020 words · 4 min read · ~3 pages · Grade level 14 · Accepted 2024-06-10 16:05:13
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SER NYSE American Indic
- $13.20 — ommon Stock "), at an exercise price of $13.20 per share, for a total purchase price o
- $4,987,818 — er share, for a total purchase price of $4,987,818. In addition to the shares of Common St
- $18.00 — Common Stock with an exercise price of $18.00 per share and expire on March 26, 2028.
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-24-023333.txt ( ) — 212KB
- ser-20240606.xsd (EX-101.SCH) — 3KB
- ser-20240606_lab.xml (EX-101.LAB) — 33KB
- ser-20240606_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SERINA THERAPEUTICS, INC. Date: June 10, 2024 By: /s/ Steven Ledger Interim Chief Executive Officer